← All medicines
Tavlesse
Licence EU/1/19/1408/001 · Unknown
- Licence holder
- Rigel Pharmaceuticals B.V. (all products →)
- Active substance
- FOSTAMATINIB
- Dosage form
- Film-coated tablet
- Route of administration
- Oral use
- ATC code
- B02BX09
- First authorised
- 09/01/2020
- Prescription status
- Product subject to prescription which may not be renewed (A)
- Supply
- Supply through pharmacies only
- Legal basis
- New active substance (Article 8(3) of Directive No 2001/83/EC)
Data: Health Products Regulatory Authority (HPRA) open dataset, licensed CC BY 4.0, published 04 Jul 2026. This listing is regulatory information, not medical advice — consult the package leaflet, SPC, or a healthcare professional. For the authoritative record see the HPRA register.